CA1271744C - Preparation of aminoglycosides - Google Patents
Preparation of aminoglycosidesInfo
- Publication number
- CA1271744C CA1271744C CA297395A CA297395A CA1271744C CA 1271744 C CA1271744 C CA 1271744C CA 297395 A CA297395 A CA 297395A CA 297395 A CA297395 A CA 297395A CA 1271744 C CA1271744 C CA 1271744C
- Authority
- CA
- Canada
- Prior art keywords
- kanamycin
- aminoglycosides
- amino group
- group
- lividomycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940126575 aminoglycoside Drugs 0.000 title abstract 4
- 125000003277 amino group Chemical group 0.000 abstract 3
- XEQLFNPSYWZPOW-UHFFFAOYSA-N Butirosin B Natural products O1C(CO)C(O)C(O)C1OC1C(O)C(NC(=O)C(O)CCN)CC(N)C1OC1OC(CN)C(O)C(O)C1N XEQLFNPSYWZPOW-UHFFFAOYSA-N 0.000 abstract 2
- 239000013522 chelant Substances 0.000 abstract 2
- 229910021645 metal ion Inorganic materials 0.000 abstract 2
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 abstract 1
- BRSBFYLXCMGALM-UHFFFAOYSA-N 5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol Chemical compound NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(CC(O)C(CO)O2)N)OC1CO BRSBFYLXCMGALM-UHFFFAOYSA-N 0.000 abstract 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
- 229930182825 Kanamycin C Natural products 0.000 abstract 1
- NAELDCSKUHFKCC-UHFFFAOYSA-N Lividomycin A Natural products NCC1OC(OC2C(O)C(OC3C(O)C(N)CC(N)C3OC4OC(CO)C(O)CC4N)OC2CO)C(N)C(O)C1OC5C(O)C(O)C(O)OC5CO NAELDCSKUHFKCC-UHFFFAOYSA-N 0.000 abstract 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 abstract 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 abstract 1
- 229930192786 Sisomicin Natural products 0.000 abstract 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229960001192 bekanamycin Drugs 0.000 abstract 1
- RHRAMPXHWHSKQB-GGEUKFTFSA-N betamicin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)O)[C@@H](N)C[C@H]1N RHRAMPXHWHSKQB-GGEUKFTFSA-N 0.000 abstract 1
- XEQLFNPSYWZPOW-SVRMBHBBSA-N butirosin A Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](CO)O1)O)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1N XEQLFNPSYWZPOW-SVRMBHBBSA-N 0.000 abstract 1
- XEQLFNPSYWZPOW-HBYCGHPUSA-N butirosin B Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](CO)O1)O)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1N XEQLFNPSYWZPOW-HBYCGHPUSA-N 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000000536 complexating effect Effects 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229960003704 framycetin Drugs 0.000 abstract 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 abstract 1
- RHRAMPXHWHSKQB-UHFFFAOYSA-N gentamicin B Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(C(O)C(O)C(CN)O2)O)C(N)CC1N RHRAMPXHWHSKQB-UHFFFAOYSA-N 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229960000318 kanamycin Drugs 0.000 abstract 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 abstract 1
- 229930182823 kanamycin A Natural products 0.000 abstract 1
- 229930182824 kanamycin B Natural products 0.000 abstract 1
- SKKLOUVUUNMCJE-FQSMHNGLSA-N kanamycin B Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SKKLOUVUUNMCJE-FQSMHNGLSA-N 0.000 abstract 1
- WZDRWYJKESFZMB-FQSMHNGLSA-N kanamycin C Chemical compound O([C@H]1[C@H](N)C[C@@H]([C@H]([C@@H]1O)O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)N)N)[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O WZDRWYJKESFZMB-FQSMHNGLSA-N 0.000 abstract 1
- 229950003076 lividomycin Drugs 0.000 abstract 1
- DBLVDAUGBTYDFR-SWMBIRFSSA-N lividomycin A Chemical compound O([C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@H]([C@H]1O)O[C@H]1O[C@H]([C@H]([C@H](O)[C@H]1N)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CN)[C@H]1O[C@H](CO)[C@@H](O)C[C@H]1N DBLVDAUGBTYDFR-SWMBIRFSSA-N 0.000 abstract 1
- 229910052759 nickel Inorganic materials 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
- 229960003485 ribostamycin Drugs 0.000 abstract 1
- 229930190553 ribostamycin Natural products 0.000 abstract 1
- NSKGQURZWSPSBC-NLZFXWNVSA-N ribostamycin Chemical compound N[C@H]1[C@H](O)[C@@H](O)[C@H](CN)O[C@@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](CO)O2)O)[C@H](O)[C@@H](N)C[C@H]1N NSKGQURZWSPSBC-NLZFXWNVSA-N 0.000 abstract 1
- NSKGQURZWSPSBC-UHFFFAOYSA-N ribostamycin A Natural products NC1C(O)C(O)C(CN)OC1OC1C(OC2C(C(O)C(CO)O2)O)C(O)C(N)CC1N NSKGQURZWSPSBC-UHFFFAOYSA-N 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 229960005456 sisomicin Drugs 0.000 abstract 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 abstract 1
- 229960000707 tobramycin Drugs 0.000 abstract 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE N-Substituted derivatives of aminoglycosides are prepared by (a) complexing an aminoglycoside with divalent metal ion selected from the group consisting of the cations of Fe, CO, Ni, Cu, Pd, Ag and Pt to form a protected species having at least one amino group bound as a metal ion chelate and at least one unbound amino group, (b) reacting the protected species with an N-acylating reagent selected from the group consisting of carboxylic and sulfonic acid anhydrides, halides and active esters to acylate at least one unbound amino group, and (c) removing the amino-protecting chelate groups. Among the aminoglycosides useful are kanamycin A, kanamycin B, kanamycin C, sisomicin, gentamicin B, tobramycin, ribostamycin, butirosin A, butirosin B, neomycin B, paromomycin I, lividomycin A and lividomycin B. The N-substituted derivatives possess utility as antibiotics or as intermediates in the preparation of aminoglycoside antibiotics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000297395A CA1271744A (en) | 1978-02-21 | 1978-02-21 | Preparation of aminoglycosides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000297395A CA1271744A (en) | 1978-02-21 | 1978-02-21 | Preparation of aminoglycosides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA1271744C true CA1271744C (en) | 1990-07-17 |
| CA1271744A CA1271744A (en) | 1990-07-17 |
Family
ID=4110829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000297395A Expired CA1271744A (en) | 1978-02-21 | 1978-02-21 | Preparation of aminoglycosides |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1271744A (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5256043B2 (en) | 2005-12-02 | 2013-08-07 | アイシス ファーマシューティカルズ， インコーポレーテッド | Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| WO2010030690A1 (en) | 2008-09-10 | 2010-03-18 | Isis Pharmaceuticals, Inc. | Antibacterial 4,6-substituted 6', 6" and 1 modified aminoglycoside analogs |
| WO2010030704A2 (en) | 2008-09-10 | 2010-03-18 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2010042851A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2010042850A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| CA2777107A1 (en) | 2009-10-09 | 2011-04-14 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2012067978A1 (en) | 2010-11-17 | 2012-05-24 | Achaogen, Inc. | Antibacterial amiinoglycoside analogs |
-
1978
- 1978-02-21 CA CA000297395A patent/CA1271744A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1271744A (en) | 1990-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2760317C2 (en) | ||
| Wright | Synthesis of 1-N-ethylsisomicin: a broad-spectrum semisynthetic aminoglycoside antibiotic | |
| CA1271744C (en) | Preparation of aminoglycosides | |
| IE39431B1 (en) | Detergent composition | |
| CH650004A5 (en) | METHOD FOR PRODUCING A SELECTIVELY PROTECTED N-ACYLATED AMINOGLYCOSIDE ANTIBIOTIC. | |
| ES426998A1 (en) | Aminoglycoside antibiotics and intermediates therefor | |
| GB1480771A (en) | Antibiotic derivatives | |
| JPS5356661A (en) | Novel amino glycoside antibiotics derivatives | |
| GB1355260A (en) | Gentamicin antibiotics | |
| IE45389L (en) | Aminoglycosides | |
| IE40796L (en) | Diaminocyclitols derivatives | |
| JPS5495548A (en) | Fortimicin ae and its preparation | |
| DE2364999A1 (en) | METHOD FOR DEHYDROXYLATION OF AMINOGLYCOSIDE ANTIBIOTICS | |
| GB1286941A (en) | Chemical reduction copper plating | |
| GB1473178A (en) | Preparation of garamine and tri-n-substituted garamine and intermediates produced thereby | |
| IE45070L (en) | Anthracycline glycoside antibiotics | |
| US4170641A (en) | 1-N-(ω-aminoalkanesulfonyl) derivative of aminoglycosidic antibiotic and process for preparation thereof | |
| US3878193A (en) | Process for the preparation of garamine derivatives | |
| GB1505355A (en) | Process for the production of 3'-deoxy derivatives of an aminoglycosidic antibiotic | |
| IE45557L (en) | Anthracycline glycosides. | |
| JPS55329A (en) | Novel xk-62-4 derivative | |
| CASSINELLI et al. | SEMISYNTHETIC AMINOGLYCOSIDE ANTIBIOTICS. II SYNTHESIS OF ANALOGUES OF PAROMOMYCIN MODIFIED IN THE GLUCOSAMINE MOIETY | |
| JPS5564598A (en) | Preparation of aminoglycoside antibiotic having selectively protected amino group | |
| US4332794A (en) | 6"-Deoxydibekacin, 4",6"-dideoxydibekacin and 1-N-aminoacyl derivatives thereof, and the production of these new compounds | |
| HANESSIAN et al. | Aminoglycoside antibiotics 4'-deoxyneomycin and 4'-deoxyparomamine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry | ||
| MKEX | Expiry |
Effective date: 20070717 |